Monday, June 13, 2005
Epitan Phase IIb "Endpoint" trial begins in Sydney, Australia
A double-blind, randomised, placebo-controlled study to evaluate the photoprotective effect of a sustained-release dose of Melanotan in fair-skinned healthy caucasians.
They are also planning the Phase III trials.
They are also planning the Phase III trials.
